A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 373 participants.
Also called NCT03467932
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 373 participants
- Sponsor
- Registry
-
NCT03467932
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03467932. Randomized; quadruple masking; primary purpose treatment. Start 2018-05-29 (actual); primary completion 2019-10-21 (actual). Results posted on 2022-11-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus
- Condition
- T2DM (Type 2 Diabetes Mellitus)
- Intervention (Drug)
- Cohort A: ORMD-0801
- Intervention (Drug)
- Placebo oral capsule
- Intervention (Drug)
- Cohort B: ORMD-0801
- Lead sponsor
- Oramed, Ltd.
- Collaborator
- Integrium
Record details
- Record id
cardio:ct-nct03467932- Content hash
871253c28a37879c74ef4e33bc9edb760911e74857b880544f2072711b7dc2ee